Clinical trial Recruiting at 1 site Early Phase 1 Interventional Ages 18 to 24

Examining how e-cigarette use affects blood vessels differently in men and women

Official title: Sex Differences in the Vascular Effects of E-cigarette Use

Run by University of Iowa · NCT06159608 · Data updated 2026-11-12

This study is testing how using e-cigarettes affects blood vessels in young men and women to see if there are any differences in their responses.

Quick facts

PhaseEarly Phase 1
Study typeInterventional
Ages18 Years to 24 Years
SexAll
Enrollment80 (estimated)
SponsorUniversity of Iowa
Academic / other
Locations1 site (Iowa City, Iowa)
StatusRecruiting
StartedDecember 2, 2023
Main results expectedDecember 2026
Study endsDecember 2026
Registry record updatedDecember 15, 2025
Trial IDNCT06159608 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are young adults aged 18-24 who are either current e-cigarette users or have never used e-cigarettes.

Probably not a fit

Patients with a history of cardiovascular or metabolic diseases, or those who have ever used tobacco cigarettes, will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the vascular effects of e-cigarette use, focusing on potential sex differences in response to vaping. Participants aged 18-24 will either be current e-cigarette users or individuals with no history of e-cigarette use. The study will utilize local heating and a nitric oxide synthase inhibitor, L-NAME, alongside chronic estrogen exposure to assess vascular function. The goal is to better understand the cardiovascular implications of e-cigarette use among young adults, a demographic with increasing prevalence of vaping.

Why it matters

Potential benefit: If successful, this study could provide insights into the cardiovascular risks associated with e-cigarette use, potentially guiding safer vaping practices.

How similar studies have gone: While there is limited research on the cardiovascular effects of e-cigarettes, this study aims to fill a gap in understanding sex differences, making it a novel approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* 18-24 years old
* one of the following:

  1. have no history of e-cigarette use
  2. be a current e-cigarette user who has been using e-cigarettes for 6 months or longer

Exclusion Criteria:

* history of cardiovascular, metabolic, and/or skin diseases
* body mass index \>30 kg/m2
* blood pressure ≥140 systolic and/or ≥ 90 diastolic
* current or history of tobacco cigarette use
* current antihypertensive or cholesterol-lowering medication
* current use of cannabis, marijuana, and/or other illegal substances
* current use of stimulant drugs
* currently pregnant or breastfeeding
* allergy to materials used during the experiment (e.g. latex),
* known allergy to study drugs
* healthy control subjects will also be excluded if they have ever used e-cigarettes in the past

Where it's running

  • University of Iowa
    Iowa City, Iowa, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.